Bibliography

Displaying 16 - 30 of 1868

Abbott 2017

Abbott Laboratories. US prescribing information. Kaletra. Available at: http://www.rxabbvie.com/pdf/kaletratabpi.pdf. October 2017. Accessed March 26, 2018.

Abdool 2010

Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010 Fe 25;362(8)697-706.

Abdool 2011

Abdool K SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011 Oct 20;365(16):1492-501.

Aberg 2004

Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004; 39(5):609-629.

Aberg 2009

Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 49(5):651-681.

Aberg 2012

Aberg JA, Tebas P, Overton ET, Gupta SK, Sax PE, Landay A, et al. Metabolic effects of darunavir/ritonavir versus ataznavir/ritonavir in treatment-naïve, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses 2012; 28(10):1184-95.

Aberg 2014

Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:1-34.

Aberg 2014a

Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014; 58(1):1-10.

Aberle 2011

Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. NEJM 2011; 365(5):395-409.

Abraham 2013

Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr 2013; 62(4):405-413.

Abraham 2015

Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, et al. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis 2015 60(6):941-949.

Abrass 2012

Abrass CK, Appelbaum JS, Boyd CM, et al. Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: Treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60:974-979.

Abutaleb 2018

Abutaleb A, Feinstein MJ. Coronary artery disease in HIV. American College of Cardiology 2018. https://www.acc.org/latest-in-cardiology/articles/2018/01/18/08/57/coronary-artery-disease-in-hiv

Achhra 2016

Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Med 2016,17:255-268.

ACOG 2016

American College of O, Gynecologists’ Committee on Practice B-G. Practice Bulletin No. 167: Gynecologic Care for Women and Adolescents With Human Immunodeficiency Virus. Obstet Gynecol 2016; 128(4):e89-e110.

Pages

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1627 Eye St NW Suite 835
Washington, D.C. 20006

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.